- Rank in Search Criteria: 2961
World Rank (Aug-2026): 9,186
Market Cap (Aug-2026): 1.013 Billion USD
World Rank (Jan-05-2024): 7,155
Market Cap (Jan-05-2024): 1.37 Billion USD
World Rank (Jul-30-2023): 6629
Market Cap (Jul-30-2023): 1.59 Billion USD
World Rank (Jan-2022): 6,536
Market Cap (Jan-2022): 1.88 Billion USDAnnual Revenue in USD: 4,325 Million USD
Annual Net Income in USD: 351 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 2962
World Rank (Aug-2026): 9,188
Market Cap (Aug-2026): 1.013 Billion USD
World Rank (Jan-05-2024): 8,228
Market Cap (Jan-05-2024): 1.08 Billion USD
World Rank (Jul-30-2023): 8472
Market Cap (Jul-30-2023): 1.06 Billion USD
World Rank (Jan-2022): 11,938
Market Cap (Jan-2022): 0.64 Billion USDHeadquarters Country: USA Annual Revenue in USD: 35 Million USD
Annual Net Income in USD: 35 Million USD
Annual Results for Period ending: Jul-2021 ending year
- Rank in Search Criteria: 2963
World Rank (Aug-2026): 9,194
Market Cap (Aug-2026): 1.012 Billion USD
World Rank (Jan-05-2024): 6,971
Market Cap (Jan-05-2024): 1.43 Billion USD
World Rank (Jul-30-2023): 9735
Market Cap (Jul-30-2023): 0.83 Billion USD
World Rank (Jan-2022): 22,233
Market Cap (Jan-2022): 0.11 Billion USDHeadquarters Country: USA Annual Revenue in USD: 407 Million USD
Annual Operating Income in USD: -41 Million USD
Annual Net Income in USD: -62 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.
Facts About Company: Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.
Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.
As on 2022, Ardelyx has 133 employees.
- Rank in Search Criteria: 2964
World Rank (Aug-2026): 9,197
Market Cap (Aug-2026): 1.012 Billion USD
World Rank (Jan-05-2024): 9,711
Market Cap (Jan-05-2024): 0.81 Billion USD
World Rank (Jul-30-2023): 9887
Market Cap (Jul-30-2023): 0.81 Billion USD
World Rank (Jan-2022): 10,695
Market Cap (Jan-2022): 0.80 Billion USDAnnual Revenue in USD: 318 Million USD
Annual Net Income in USD: 141 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 2965
World Rank (Aug-2026): 9,198
Market Cap (Aug-2026): 1.012 Billion USD
World Rank (Jan-05-2024): 10,496
Market Cap (Jan-05-2024): 0.71 Billion USD
World Rank (Jul-30-2023): 11053
Market Cap (Jul-30-2023): 0.66 Billion USD
World Rank (Jan-2022): 8,079
Market Cap (Jan-2022): 1.31 Billion USDAnnual Revenue in USD: 250 Million USD
Annual Net Income in USD: 85 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 2966
World Rank (Aug-2026): 9,204
Market Cap (Aug-2026): 1.011 Billion USD
World Rank (Jan-05-2024): 9,536
Market Cap (Jan-05-2024): 0.84 Billion USD
World Rank (Jul-30-2023): 8898
Market Cap (Jul-30-2023): 0.97 Billion USD
World Rank (Jan-2022): 8,507
Market Cap (Jan-2022): 1.20 Billion USDHeadquarters Country: USA Annual Revenue in USD: 1,331 Million USD
Annual Operating Income in USD: 108 Million USD
Annual Net Income in USD: 51 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 1,300
Employee Count as of Date: As on 2022
Company Profile: Accel Entertainment is a Gaming Provider company operate slot machines and amusement equipment.The headquarters is in USA.
Facts About Company: Accel Entertainment Annual Total Revenue for year ending Dec-2022 was 969 million USD and and Net Income for year ending Dec-2022 was 74 million USD.
Accel Entertainment Annual Total Revenue for year ending Dec-2021 was 734 million USD and and Net Income for year ending Dec-2021 was 31 million USD.
As on 2022, Accel Entertainment has 1,300 employees.
- Rank in Search Criteria: 2967
World Rank (Aug-2026): 9,206
Market Cap (Aug-2026): 1.010 Billion USD
World Rank (Jan-05-2024): 18,100
Market Cap (Jan-05-2024): 0.19 Billion USD
World Rank (Jul-30-2023): 20472
Market Cap (Jul-30-2023): 0.13 Billion USD
World Rank (Jan-2022): 19,599
Market Cap (Jan-2022): 0.18 Billion USDHeadquarters Country: USA Annual Revenue in USD: 847 Million USD
Annual Operating Income in USD: 267 Million USD
Annual Net Income in USD: 196 Million USD
Annual Results for Period ending: For year ending December-2025
- Rank in Search Criteria: 2968
World Rank (Aug-2026): 9,216
Market Cap (Aug-2026): 1.007 Billion USD
World Rank (Jan-05-2024): 9,640
Market Cap (Jan-05-2024): 0.82 Billion USD
World Rank (Jul-30-2023): 9671
Market Cap (Jul-30-2023): 0.84 Billion USD
World Rank (Jan-2022): 9,720
Market Cap (Jan-2022): 0.95 Billion USDHeadquarters Country: USA Annual Revenue in USD: 180 Million USD
Annual Net Income in USD: 180 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 2969
World Rank (Aug-2026): 9,229
Market Cap (Aug-2026): 1.003 Billion USD
World Rank (Jan-05-2024): 6,530
Market Cap (Jan-05-2024): 1.60 Billion USD
World Rank (Jul-30-2023): 6164
Market Cap (Jul-30-2023): 1.79 Billion USD
World Rank (Jan-2022): 5,276
Market Cap (Jan-2022): 2.66 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: 0 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: BLACKROCK HEALTH SCIENCES TRUST II is one of the world’s leading providers of investment, advisory and risk management solutions. Headquarters is in USA.
- Rank in Search Criteria: 2970
World Rank (Aug-2026): 9,234
Market Cap (Aug-2026): 1.003 Billion USD
World Rank (Jan-05-2024): 14,389
Market Cap (Jan-05-2024): 0.38 Billion USD
World Rank (Jul-30-2023): 18916
Market Cap (Jul-30-2023): 0.17 Billion USD
World Rank (Jan-2022): 16,216
Market Cap (Jan-2022): 0.32 Billion USDHeadquarters Country: USA Annual Operating Income in USD: -216 Million USD
Annual Net Income in USD: -207 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 38
Employee Count as of Date: As on September 2020
Company Profile: Annexon Biosciences is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing breakthrough therapeutics for autoimmune and neurodegenerative disease. It is having 38 employees as on September 2020. The headquarters is in USA.